India Piriformis Syndrome Market Research Report By Cause (Trauma, Spasms, Others)- Forecast to 2035
ID: MRFR/HC/55054-HCR | 200 Pages | Author: Rahul Gotadki| June 2025
As per MRFR analysis, the India Piriformis Syndrome Market Size was estimated at 7.35 (USD Million) in 2023. The India Piriformis Syndrome Market Industry is expected to grow from 7.79(USD Million) in 2024 to 15.58 (USD Million) by 2035. The India Piriformis Syndrome Market CAGR (growth rate) is expected to be around 6.499% during the forecast period (2025 - 2035).
Key India Piriformis Syndrome Market Trends Highlighted
The India Piriformis Syndrome market is seeing a notable rise in awareness and diagnosis of this condition, largely driven by increasing incidences of conditions like sciatica and lower back pain, which are recognized by healthcare professionals as closely associated with piriformis syndrome. With the population in India becoming more health-conscious and seeking timely medical advice, doctors are more frequently identifying this condition in patients, contributing to a growing demand for targeted treatments and therapies.
Additionally, the integration of advanced diagnostic techniques, such as ultrasound and MRI, has improved the accuracy of identifying piriformis syndrome, thereby facilitating prompt management.Equally important, the other facets of treatment, including physical therapy and unique pain relief methods associated with this ailment, present an opportunity in regard to product development.
The growing popularity of physiotherapy as a non-invasive treatment has created a demand for advanced rehabilitation programs designed for patients with piriformis syndrome. The construction and growth of physiotherapy clinics in cities are also spurring the growth of this market. Recently, there has been heightened engagement among Indian education partners in healthcare services to promote awareness of piriformis syndrome and its treatment.
Initiatives aimed at educating both healthcare professionals and patients about the condition have been launched, reflecting a trend towards holistic health. Additionally, the digital health revolution is allowing patients more access to information and telehealth services for managing their symptoms effectively. This shift is anticipated to bolster treatment accessibility and encourage early intervention for the growing number of individuals affected by piriformis syndrome in India.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Piriformis Syndrome Market Drivers
Increase in Sedentary Lifestyle and Related Health Issues
The rise of a sedentary lifestyle, especially in urban areas of India, has significantly contributed to the prevalence of musculoskeletal disorders, including Piriformis Syndrome. According to a study by the Indian Council of Medical Research, nearly 60% of adults in urban settings engage in minimal physical activity, making them more susceptible to conditions like Piriformis Syndrome.
This trend is further supported by the increasing number of desk jobs and digital technology usage, which has risen by 30% in the past decade.Major health organizations in India, including the Ministry of Health and Family Welfare, have recognized this trend and are initiating programs aimed at increasing physical activity among the populace. The increasing caseload due to sedentary lifestyles is expected to drive the India Piriformis Syndrome Market Industry as treatment options become more sought after, resulting in a compound annual growth rate of approximately 6.499% from 2025 to 2035.
Growing awareness of Piriformis Syndrome
With the proliferation of health information through online platforms and social media, there has been a notable increase in awareness regarding Piriformis Syndrome among the Indian population. Research indicates that awareness campaigns led by medical associations, such as the Indian Medical Association, have increased public knowledge about this condition by approximately 40% over the past five years.
As more individuals recognize the symptoms and seek appropriate medical care, consultation rates have risen, thereby expanding the market for treatment options and therapies dedicated to Piriformis Syndrome.This trend not only boosts the market's growth but also encourages further Research and Development initiatives in this domain.
Advancements in healthcare infrastructure
India has been making significant strides in enhancing its healthcare infrastructure, which is crucial for the diagnosis and treatment of conditions like Piriformis Syndrome. The Indian government's initiatives to establish more healthcare facilities and upgrade existing ones have seen a budget allocation increase by 15% in the recent fiscal year.
The implementation of telemedicine and digital health platforms has also expanded accessibility to specialists for patients suffering from Piriformis Syndrome, leading to better diagnosis and management of the condition.As healthcare infrastructure continues to evolve, the India Piriformis Syndrome Market Industry will benefit from increased patient consultations and treatment adherence, thereby accelerating market growth.
India Piriformis Syndrome Market Segment Insights
Piriformis Syndrome Market Cause Insights
The India Piriformis Syndrome Market, specifically focusing on the Cause segment, covers various underlying factors responsible for this condition, with notable categories being Trauma, Spasms, and Others. Trauma is often recognized as an essential contributor caused by injuries to the hip, pelvis, or lower spine, which may lead to the entrapment of the sciatic nerve by the piriformis muscle. This segment is significant since the increasing incidence of sports-related injuries, vehicular accidents, and falls in India fuels the prevalence of trauma-related cases.On the other hand, Spasms play a crucial role in Piriformis Syndrome, as muscular tightness or spasms in the piriformis can cause discomfort and compress the sciatic nerve, resulting in pain.
This issue is becoming increasingly relevant in the context of rising sedentary lifestyles and poor posture habits prevalent in urban India, making Spasms a leading cause among the population. The 'Others' category encompasses a range of additional factors, such as anatomical anomalies or underlying conditions that could lead to Piriformis Syndrome. While these may not be as frequently recognized, they represent a diverse array of issues that healthcare professionals in India must address to provide effective treatment.
As healthcare awareness and diagnostic capabilities evolve in India, the understanding of these causal mechanisms becomes integral for effective management and intervention strategies. The overall dynamics of the India Piriformis Syndrome Market segmentation highlight the complexities surrounding causes, underlining the need for tailored therapeutic approaches to ensure comprehensive care for affected individuals. Together, these aspects of the Cause segment reveal important insights into the challenges and opportunities in addressing Piriformis Syndrome, particularly in a diverse population with varied health profiles and lifestyles.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Piriformis Syndrome Market Key Players and Competitive Insights
The India Piriformis Syndrome Market is characterized by a growing recognition of the condition and the subsequent demand for effective treatment options within the country. As healthcare providers expand their services to address musculoskeletal conditions, there is increasing clarity on the players dominating this niche market. Insights reveal that the market is witnessing an upsurge in awareness among patients regarding symptoms and treatment options, thus propelling growth in diagnostic and therapeutic services. The competitive landscape is evolving as medical facilities enhance their offerings, adopting innovative approaches and leveraging advanced technology to improve patient outcomes. With a clear understanding of market dynamics, both existing players and new entrants are strategically positioning themselves to capture a larger share by focusing on patient-centric solutions and comprehensive care.
Kokilaben Dhirubhai Ambani Hospital stands out in the India Piriformis Syndrome Market due to its state-of-the-art facilities and a multi-disciplinary approach towards the treatment of various orthopedic and neuromuscular conditions. The hospital's focus on advanced diagnostic tools enables precise identification of Piriformis Syndrome, allowing for timely and effective treatment. Its strong emphasis on personalized patient care and rehabilitation programs contributes positively to the overall treatment experience. With a broad spectrum of expert healthcare professionals and specialists on board, Kokilaben Dhirubhai Ambani Hospital has established itself as a trusted name for patients seeking care for Piriformis Syndrome and related disorders in India. Continuous investment in training and education equips their medical staff with the latest knowledge and practices in managing such conditions, reinforcing their position as a leading player in this market.
Asian Heart Institute, while primarily recognized for its cardiology services, also plays a vital role in the India Piriformis Syndrome Market through an integrated approach involving pain management and rehabilitation services. The hospital offers a range of therapeutic options, including physiotherapy and surgical interventions, specifically aimed at addressing issues related to Piriformis Syndrome. Its commitment to incorporating evidence-based practices and cutting-edge technology has led to a solid reputation for high-quality healthcare services. Asian Heart Institute's strategic partnerships and potential mergers with specialized clinics further enhance its market presence, allowing it to cater to a broader patient demographic. By focusing on a holistic approach to treatment and rehabilitation, the institute aligns itself well with the evolving healthcare landscape in India, ensuring comprehensive care for those affected by Piriformis Syndrome.
Key Companies in the India Piriformis Syndrome Market Include:
India Piriformis Syndrome Market Industry Developments
Recent developments in the India Piriformis Syndrome Market indicate a growing awareness and focus on this condition, particularly in urban healthcare settings. Leading hospitals such as Kokilaben Dhirubhai Ambani Hospital, Max Healthcare, and Apollo Hospitals have expanded their services to include specialized treatments for musculoskeletal pain, including Piriformis Syndrome.
In terms of current affairs, the increasing prevalence of lifestyle diseases in India has catalyzed a rise in patient consultations related to Piriformis Syndrome, paving the way for enhanced diagnostic services and physical therapy solutions.In recent years, there have been notable advancements in treatment methodologies, including minimally invasive surgical options and advanced physiotherapy techniques.
Growth in market valuation has been observed as major healthcare players like Wockhardt Hospitals and Medanta implement innovative care protocols. While there have been no publicly disclosed mergers or acquisitions specific to the Piriformis Syndrome Market among these hospitals recently, ongoing strategic partnerships aimed at enhancing patient care and expanding service offerings are anticipated. Overall, the market landscape is transforming, with patients increasingly seeking specialized care for this condition across India.
India Piriformis Syndrome Market Segmentation Insights
Piriformis Syndrome Market Cause Outlook
Report Attribute/Metric Source: | Details |
MARKET SIZE 2023 | 7.35(USD Million) |
MARKET SIZE 2024 | 7.79(USD Million) |
MARKET SIZE 2035 | 15.58(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.499% (2025 - 2035) |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR | 2024 |
MARKET FORECAST PERIOD | 2025 - 2035 |
HISTORICAL DATA | 2019 - 2024 |
MARKET FORECAST UNITS | USD Million |
KEY COMPANIES PROFILED | Kokilaben Dhirubhai Ambani Hospital, Asian Heart Institute, Wockhardt Hospitals, Max Healthcare, Scripps Health, Manipal Hospitals, Apollo Hospitals, Breach Candy Hospital, Sankara Nethralaya, Care Hospitals, RTI Health Solutions, Fortis Healthcare, Narayana Health, Medanta |
SEGMENTS COVERED | Cause |
KEY MARKET OPPORTUNITIES | Growing awareness of condition, Increased demand for therapy options, Expansion of healthcare infrastructure, Rise in sports-related injuries, Development of targeted pain relief products |
KEY MARKET DYNAMICS | increasing prevalence of lifestyle disorders, rising awareness of treatment options, advancements in diagnostic technologies, growing healthcare infrastructure, availability of specialized healthcare professionals |
COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Piriformis Syndrome Market is expected to be valued at 7.79 USD Million in 2024.
By 2035, the India Piriformis Syndrome Market is projected to reach a value of 15.58 USD Million.
The expected CAGR for the India Piriformis Syndrome Market from 2025 to 2035 is 6.499%.
Key players in the India Piriformis Syndrome Market include major healthcare providers such as Apollo Hospitals, Max Healthcare, and Fortis Healthcare.
The market value for Piriformis Syndrome attributed to trauma in 2024 is 3.1 USD Million.
The market attributed to spasms is expected to grow to 5.0 USD Million by 2035.
In 2024, the market size for other causes of Piriformis Syndrome is valued at 2.19 USD Million.
There are opportunities for growth driven by increasing awareness and advancements in healthcare technologies.
Challenges include the need for better diagnosis and treatment options for patients suffering from Piriformis Syndrome.
Regional healthcare developments and infrastructure improvements are positively impacting the growth of the India Piriformis Syndrome Market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)